Page last updated: 2024-09-05

yttrium ethylenediaminetetra(methylenephosphonic acid) and Cancer of Prostate

yttrium ethylenediaminetetra(methylenephosphonic acid) has been researched along with Cancer of Prostate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braun, U; Herzog, H; Müller-Gärtner, HW; Neumaier, B; Plag, C; Rösch, F; Stöcklin, G1

Other Studies

1 other study(ies) available for yttrium ethylenediaminetetra(methylenephosphonic acid) and Cancer of Prostate

ArticleYear
Radiation doses of yttrium-90 citrate and yttrium-90 EDTMP as determined via analogous yttrium-86 complexes and positron emission tomography.
    European journal of nuclear medicine, 1996, Volume: 23, Issue:8

    Topics: Aged; Aged, 80 and over; Bone Marrow; Bone Neoplasms; Citrates; Humans; Male; Middle Aged; Organometallic Compounds; Organophosphonates; Palliative Care; Prostatic Neoplasms; Radiotherapy Dosage; Tomography, Emission-Computed; Yttrium Radioisotopes

1996